OncoTracker Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $150K
Latest Deal Amount

OncoTracker General Information

Description

Provider of medical diagnostics services intended to detect and cure cancer and other diseases. The company's assay is based on measuring B-cell maturation antigen (BCMA) and helps in monitoring and predicting outcomes for multiple myeloma and chronic lymphocytic leukemia patients, making it possible to more rapidly and accurately assess changes in a patient's cancer and further predict treatment efficacy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Diagnostic Equipment
Monitoring Equipment
Primary Office
  • 9201 Sunset Boulevard
  • Suite 300
  • West Hollywood, CA 90069
  • United States
+1 (424) 000-0000

OncoTracker Timeline

2018201920202021
Financing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoTracker Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 13-Feb-2020 $150K 00000 Completed Startup
2. Angel (individual) 13-Mar-2019 0000 0000 Completed Startup
1. Angel (individual) 10-Nov-2016 $1.12M Completed Startup
To view OncoTracker’s complete valuation and funding history, request access »

OncoTracker Patents

OncoTracker Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3873478-A2 Method of enhancing immune-based therapy Pending 31-Oct-2018 000000000000
US-20200264184-A1 Diagnostic, prognostic, and monitoring methods for solid tumor cancers Pending 13-Jun-2017 000000000000
EP-3324965-A4 Gamma secretase modulators for the treatment of immune system dysfunction Withdrawn 24-Jul-2015 0000000000 0
EP-3662909-A1 Gamma secretase modulators for the treatment of immune system dysfunction Pending 24-Jul-2015 000000000 00
EP-3324965-A1 Gamma secretase modulators for the treatment of immune system dysfunction Withdrawn 24-Jul-2015 A61K31/145

OncoTracker Executive Team (4)

Name Title Board Seat Contact Info
James Berenson MD Co-Founder, President, Chief Scientific Officer & Board Member
James Kuo MD Chief Executive Officer
Tom Gosney Chief Operating Officer & Chief Financial Officer
Geoffrey Gee ESQ Treasurer, Secretary & Board Member
To view OncoTracker’s complete executive team members history, request access »

OncoTracker Board Members (3)

Name Representing Role Since
Geoffrey Gee ESQ Self Treasurer, Secretary & Board Member 000 0000
James Berenson MD OncoTracker Co-Founder, President, Chief Scientific Officer & Board Member 000 0000
Ron Rogers OncoTracker Board Member 000 0000
To view OncoTracker’s complete board members history, request access »